Medical-Surgical Intensive Care Unit, District Hospital Center, La Roche-sur-Yon, France.
JAMA. 2013 Jan 16;309(3):249-56. doi: 10.1001/jama.2012.196377.
Monitoring of residual gastric volume is recommended to prevent ventilator-associated pneumonia (VAP) in patients receiving early enteral nutrition. However, studies have challenged the reliability and effectiveness of this measure.
To test the hypothesis that the risk of VAP is not increased when residual gastric volume is not monitored compared with routine residual gastric volume monitoring in patients receiving invasive mechanical ventilation and early enteral nutrition.
DESIGN, SETTING, AND PATIENTS: Randomized, noninferiority, open-label, multicenter trial conducted from May 2010 through March 2011 in adults requiring invasive mechanical ventilation for more than 2 days and given enteral nutrition within 36 hours after intubation at 9 French intensive care units (ICUs); 452 patients were randomized and 449 included in the intention-to-treat analysis (3 withdrew initial consent).
Absence of residual gastric volume monitoring. Intolerance to enteral nutrition was based only on regurgitation and vomiting in the intervention group and based on residual gastric volume greater than 250 mL at any of the 6 hourly measurements and regurgitation or vomiting in the control group.
Proportion of patients with at least 1 VAP episode within 90 days after randomization, as assessed by an adjudication committee blinded to patient group. The prestated noninferiority margin was 10%.
In the intention-to-treat population, VAP occurred in 38 of 227 patients (16.7%) in the intervention group and in 35 of 222 patients (15.8%) in the control group (difference, 0.9%; 90% CI, -4.8% to 6.7%). There were no significant between-group differences in other ICU-acquired infections, mechanical ventilation duration, ICU stay length, or mortality rates. The proportion of patients receiving 100% of their calorie goal was higher in the intervention group (odds ratio, 1.77; 90% CI, 1.25-2.51; P = .008). Similar results were obtained in the per-protocol population.
Among adults requiring mechanical ventilation and receiving early enteral nutrition, the absence of gastric volume monitoring was not inferior to routine residual gastric volume monitoring in terms of development of VAP.
clinicaltrials.gov Identifier: NCT01137487.
监测残余胃容量有助于预防接受早期肠内营养的患者发生呼吸机相关性肺炎(VAP)。然而,一些研究对该措施的可靠性和有效性提出了质疑。
验证以下假设,即在接受有创机械通气和早期肠内营养的患者中,与常规监测残余胃容量相比,不监测残余胃容量并不会增加 VAP 风险。
设计、设置和患者:2010 年 5 月至 2011 年 3 月期间,在 9 个重症监护病房(ICU)中,对需要接受有创机械通气超过 2 天且在插管后 36 小时内接受肠内营养的成人患者进行了一项随机、非劣效性、开放标签、多中心试验;共纳入 452 例患者,其中 449 例患者被随机分组且纳入意向治疗分析(3 例患者撤回了最初的同意)。
不监测残余胃容量。干预组中,肠内营养不耐受仅基于反流和呕吐,而对照组中,肠内营养不耐受基于任何 6 小时测量时的残余胃容量大于 250 mL 且出现反流或呕吐。
在随机分组后 90 天内至少发生 1 例 VAP 发作的患者比例,由一个对患者分组不知情的裁决委员会评估。预先设定的非劣效性界值为 10%。
在意向治疗人群中,干预组 227 例患者中有 38 例(16.7%)发生 VAP,对照组 222 例患者中有 35 例(15.8%)发生 VAP(差异,0.9%;90%CI,-4.8%至 6.7%)。两组间其他 ICU 获得性感染、机械通气时间、ICU 住院时间或死亡率无显著差异。干预组接受 100%热量目标的患者比例更高(比值比,1.77;90%CI,1.25-2.51;P =.008)。在符合方案人群中也得到了类似的结果。
在需要机械通气和接受早期肠内营养的成人患者中,与常规监测残余胃容量相比,不监测残余胃容量在 VAP 发生方面并不劣于常规监测残余胃容量。
clinicaltrials.gov 标识符:NCT01137487。